Alzheimer’s Disease biomarkers: a population perspective
Biomarkers provide a dynamic and powerful approach to understanding the spectrum of diseases from the earliest manifestations to the terminal stages. A recently published framework for the diagnosis of Alzheimer’s Disease (AD) in research studies would allow diagnosis on the sole basis of two biomarkers (-amyloid and tau). This revision will have substantial implications for future Alzheimer’s research. We will discuss the conditions that need to be met (validity, reliability, innovation) for this new diagnostic framework to foster identification of effective strategies to prevent or treat AD.
Date: 16 October 2018, 9:30 (Tuesday, 2nd week, Michaelmas 2018)
Venue: Warneford Hospital, Headington OX3 7JX
Venue Details: Seminar Room, University Department of Psychiatry
Speaker: Professor Carole Dufouil (Research Professor, Inserm, Bordeaux School of Public Health, Bordeaux, France)
Organising department: Department of Psychiatry
Organiser: Tracy Lindsey
Part of: Psychiatry Seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Tracy Lindsey